Anti-histones antibodies in systemic lupus erythematosus: Prevalence and frequency in neuropsychiatric lupus

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 4, 2008, Pages 271-277

  Sun, Xiao Yun ^a   Shi, Jinxia ^a   Han, Lei ^a   Su, Yin ^a   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Autoantibody; Histones; Neuropsychiatric lupus; Systemic lupus erythematosus

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; HISTONE H1; HISTONE H3; IMMUNOGLOBULIN G ANTIBODY; NUCLEOSOME ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMATIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC LUPUS; PREVALENCE; RHEUMATIC DISEASE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEQUENTIAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; DNA; FEMALE; HEMATOLOGIC TESTS; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 48249110312     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20248     Document Type: Article

References (39)

1. Tan EM. An immunologic precipitin system between soluble nucleo-protein and serum antibody in systemic lupus erythematosus. J Clin Invest 1967;46:735-745.
2. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probe for cell biology. Adv Immunol 1989;44:93-151.
3. Wallace DJ, Hahn BH, Quismorio FP, et al. 2007. Dubois' Lupus Erythematosus. Philadelphia, PA: Lea & Febinger. p 464-479.
4. Pisetsky DA. Anti-DNA antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:437-454.
5. Fritzler MJ, Tan EM. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 1978;62;560-567.
6. Gioud M, Ait Kaci M, Monier JC. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum 1982;25:407-413.
7. Chabre H, Amoura Z, Piette JC, et al. Presence of nucleosome restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995;38:1485-1491.
8. Mohan C, Adams S, Stanik V, et al. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993;177:1367-1381.
9. Burlingame RW, Boey ML, Starkebaum G, et al. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94;184-192.
10. Lefkowitz JB, Kiehl M, Rubenstein J, et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 1996;98;1373-1380.
11. van Bruggen MC, Kramers C, Walgreen B, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997;12:57-66.
12. Kramers C, Hylkema MN, van Bruggen MC, et al. Antinucleosomal antibodies complexed to nucleosomal antigens show anti-dsDNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994;94;568-577.
13. Elouaai F, Lule L, Benoist H, et al. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol Dial Transplant 1994;9:362-366.
14. González C, Garcia-Berrocal B, Herráez O, et al. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus. Clin Chem Lab Med 2004;42:266-272.
15. Cortés-Hernández J, Ordi-Ros J, Labrador M, et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004;116:165-173.
16. Lakatos A, Sétáló J, Jobst K, et al. Relationship of serum antihistone antibody level to the patient's age. Acta Med Hung 1992-1993;49:91-100.
17. Gompertz NR, Isenberg DA, Turner BM. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis 1990;49:524-527.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
19. Bombardier C, Gland DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
21. Schett G, Rubin RL, Steiner G, et al. The lupus erythematosus cell (LEC) phenomenon: Comparative analysis of anti-chromatin antibody specificity in LEC positive and LEC negative sera. Arthritis Rheum 2000;43:420-428.
22. Chen HY, Jia RL, Li ZG. Significance of anti-cell membrane-associated DNA (mDNA) antibodies in systemic lupus erythematosus. Chin J Rheumatol 2005;9:229-233.
23. Suzuki T, Burlingame RW, Casiano CA, et al. Antihistone antibodies in systemic lupus erythematosus: Assay dependency and effects of ubiquitination and serum DNA. J Rheumatol 1994;21:1081-1091.
24. Viard JP, Choquette D, Chabre H, et al. Anti-histone reactivity in systemic lupus erythematosus sera: A disease activity index linked to the presence of DNA:anti-DNA immune complexes. Autoimmunity 1992;12:61-68.
25. Cohen MG, Webb J. Antihistone antibodies in rheumatoid arthritis and Felty syndrome. Arthritis Rheum 1989;32:1319-1324.
26. Sato S, Ihn H, Kikuchi K, et al. Antihistone antibodies in systemic sclerosis. Arthritis Rheum 1994;37:391-394.
27. Cervera R, Vinas O, Ramos-Casals M, et al. Anti-chromatin antibodies in systemic lupus erythematosus: A useful marker for lupus nephropathy. Ann Rheum Dis 2003;62:431-434.
28. Kubo M, Ihn H, Yazawa N, et al. Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis. J Invest Dermatol 1999;112:711-715.
29. Fritzler MJ, Ryan P, Kinsella TD. Clinical features of systemic lupus erythematosus patients with antihistone antibodies. J Rheumatol 1982;9:46-51.
30. Epstin A, Greeberg M, Halpert S, et al. The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol 1986;13:304-307.
31. Muller S, Barakat S, Watts R, et al. Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. Clin Exp Rheumatol 1990;8:445-453.
32. Bernstein RM, Hobbs RN, Lea DJ, et al. Patterns of antihistone antibody specificity in systemic rheumatic disease. Arthritis Rheum 1985;28:285-293.
33. Gioud M, Aitkaci A, Monier JC. Histone antibodies in systemic lupus erythematosus. Arthritis Rheum 1982;25:407-413.
34. Klajman A, Kafri B, Shohat T, et al. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients and in rheumatoid-like disease. Clin Immunol Immunopathol 1983;27:1-8.
35. Fishbein E, Alarcon-Segovia D, Vega JM. Antibodies to histones in systemic lupus erythematosus. Clin Exp Immunol 1979;36:145-150.
36. Aitkaci A, Monier JC, Mamelle N. Enzyme-linked immunosorbent assay for antihistone antibodies and their presence in systemic lupus erythematosus sera. J Immunol Methods 1981;44:411-422.
37. Cohen MG, Pollard KM, Webb J. Antibodies to histone in systemic lupus erythematosus: Prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis 1992;51:61-66.
38. Sxhett G, Smmolen J, Zimmermann C, et al. The autoimmune response to chromatin antigens in systemic lupus erythematosus; autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity. Lupus 2002;11:704-715.
39. ACR Ad Hoc Committee on Neuropyschiatric Lupus Nomenclature. The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.